Arnold C. Hanish - 21 Aug 2020 Form 4/A - Amendment Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/David Arthur, as Attorney-in-Fact
Issuer symbol
SLRX
Transactions as of
21 Aug 2020
Net transactions value
+$3,920
Form type
4/A - Amendment
Filing time
06 Jun 2022, 20:31:19 UTC
Date Of Original Report
24 Aug 2020
Previous filing
06 Jun 2022
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Purchase $3,920 +4,000 +54% $0.9800 11,350 21 Aug 2020 By Arnold C. Hanish Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on August 24, 2020 to reflect that the securities reported are indirectly beneficially owned as indicated herein.